Suppr超能文献

与胰腺腺癌的部分胰腺切除术相比,全胰腺切除术:来自美国国家癌症数据库的切除边缘、再入院率和生存率评估。

Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.

机构信息

Department of Surgery, Division of Hepatopancreatobiliary Surgery, Carolinas Medical Center, Charlotte, NC, U.S.A.

Center for Outcomes Research and Evaluation, Carolinas HealthCare System, Charlotte, NC, U.S.A.

出版信息

Curr Oncol. 2019 Jun;26(3):e346-e356. doi: 10.3747/co.26.4066. Epub 2019 Jun 1.

Abstract

INTRODUCTION

Total pancreatectomy for pancreatic ductal adenocarcinoma has historically been associated with substantial patient morbidity and mortality. Given advancements in perioperative and postoperative care, evaluation of the surgical treatment options for pancreatic adenocarcinoma should consider patient outcomes and long-term survival for total pancreatectomy compared with partial pancreatectomy.

METHODS

The U.S. National Cancer Database was queried for patients undergoing total pancreatectomy or partial pancreatectomy for pancreatic adenocarcinoma during 1998-2006. Demographics, tumour characteristics, operative outcomes, 30-day mortality, 30-day readmission, additional treatment, and Kaplan-Meier survival curves were compared.

RESULTS

The database query returned 807 patients who underwent total pancreatectomy and 5840 who underwent partial pancreatectomy. More patients who underwent total pancreatectomy than a partial pancreatectomy had a margin-negative resection ( < 0.0001). Mortality and readmission rates were similar in the two groups, as was long-term survival on Kaplan-Meier curves ( = 0.377). A statistically significant difference in the rate of surgery only (without additional treatment) was observed for patients in the total pancreatectomy group ( = 0.0003).

CONCLUSIONS

Although total compared with partial pancreatectomy was associated with a higher rate of margin-negative resection, median survival was not significantly different for patients undergoing either procedure. Patients who underwent total pancreatectomy were significantly less likely to receive adjuvant therapy.

摘要

简介

历史上,全胰切除术治疗胰腺导管腺癌与患者较高的发病率和死亡率相关。鉴于围手术期和术后护理的进步,在评估胰腺腺癌的手术治疗方案时,应考虑全胰切除术与胰部分切除术相比患者的结局和长期生存率。

方法

在美国国家癌症数据库中查询了 1998 年至 2006 年间接受全胰切除术或胰部分切除术治疗胰腺导管腺癌的患者。比较了患者的人口统计学、肿瘤特征、手术结果、30 天死亡率、30 天再入院率、辅助治疗和 Kaplan-Meier 生存曲线。

结果

数据库查询返回了 807 例接受全胰切除术和 5840 例接受胰部分切除术的患者。与接受胰部分切除术的患者相比,更多接受全胰切除术的患者有阴性切缘(<0.0001)。两组患者的死亡率和再入院率相似,Kaplan-Meier 曲线显示长期生存率也相似(=0.377)。接受全胰切除术的患者仅接受手术(无其他治疗)的比例明显高于接受胰部分切除术的患者(=0.0003)。

结论

尽管与胰部分切除术相比,全胰切除术与阴性切缘率更高相关,但接受两种手术的患者的中位生存期没有显著差异。接受全胰切除术的患者接受辅助治疗的可能性明显较低。

相似文献

2
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21.
3
Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Br J Surg. 2018 Aug;105(9):1171-1181. doi: 10.1002/bjs.10842. Epub 2018 May 8.
4
Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
ANZ J Surg. 2015 Apr;85(4):270-3. doi: 10.1111/ans.12585. Epub 2014 Apr 9.
5
Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Ann Surg. 2009 Aug;250(2):282-7. doi: 10.1097/SLA.0b013e3181ae9f93.
8
Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
Br J Surg. 2016 Nov;103(12):1683-1694. doi: 10.1002/bjs.10221. Epub 2016 Sep 30.
9
A reappraisal of total pancreatectomy for pancreatic cancer: results from U.S. Veterans Affairs hospitals, 1987-1991.
Am J Surg. 1994 Dec;168(6):582-5; discussion 585-6. doi: 10.1016/s0002-9610(05)80126-6.

引用本文的文献

2
A more radical perspective on surgical approach and outcomes in pancreatic cancer-a narrative review.
J Gastrointest Oncol. 2023 Aug 31;14(4):1964-1981. doi: 10.21037/jgo-22-763. Epub 2023 Mar 7.
5
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.
Front Oncol. 2021 Jul 15;11:688377. doi: 10.3389/fonc.2021.688377. eCollection 2021.
7
Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.
Front Oncol. 2020 Oct 29;10:598048. doi: 10.3389/fonc.2020.598048. eCollection 2020.

本文引用的文献

1
Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.
J Surg Res. 2017 Dec;220:12-24. doi: 10.1016/j.jss.2017.06.076. Epub 2017 Jul 24.
3
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
Gut. 2017 Aug;66(8):1354-1355. doi: 10.1136/gutjnl-2016-312529. Epub 2016 Dec 9.
4
The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery.
Ann Surg Oncol. 2018 Jan;25(1):51-58. doi: 10.1245/s10434-016-5676-3. Epub 2016 Nov 23.
5
Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center.
World J Gastrointest Surg. 2016 Sep 27;8(9):634-642. doi: 10.4240/wjgs.v8.i9.634.
6
Management of pancreatogenic diabetes: challenges and solutions.
Diabetes Metab Syndr Obes. 2016 Aug 25;9:311-5. doi: 10.2147/DMSO.S99701. eCollection 2016.
7
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach.
Ann Surg Oncol. 2016 Dec;23(13):4156-4164. doi: 10.1245/s10434-016-5457-z. Epub 2016 Jul 26.
9
Operative Trends for Pancreatic Diseases in the USA: Analysis of the Nationwide Inpatient Sample from 1998-2011.
J Gastrointest Surg. 2016 Apr;20(4):803-11. doi: 10.1007/s11605-015-3067-x. Epub 2016 Jan 20.
10
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验